Number of people having started treatment with Truvada® or generic for pre-exposure prophilaxis (PrEP) between the 1st semester of 2016 and the 1st semester of 2021, by region
Characteristic
Number of people
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The chart is not accessible to screen readers. Please switch to the table view to access the data.
You need a ÌÇÐÄÆƽâ°æ Account for unlimited access
This graph shows the number of people having initiated treatment for pre-exposure prophylaxis (PrEP) against the human immunodeficiency viruses (HIV) on a regional scale in France. Between January 2016 and June 2021, more than ** thousand people had started such a treatment in the French region of ÃŽle-de-France.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
ANSM. (November 30, 2021). Number of people having started treatment with Truvada® or generic for pre-exposure prophilaxis (PrEP) between the 1st semester of 2016 and the 1st semester of 2021, by region [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 01, 2026, from /statistics/1116558/hiv-aids-prep-initiations-france-region/
ANSM. "Number of people having started treatment with Truvada® or generic for pre-exposure prophilaxis (PrEP) between the 1st semester of 2016 and the 1st semester of 2021, by region." Chart. November 30, 2021. ÌÇÐÄÆƽâ°æ. Accessed August 01, 2026. /statistics/1116558/hiv-aids-prep-initiations-france-region/
ANSM. (2021). Number of people having started treatment with Truvada® or generic for pre-exposure prophilaxis (PrEP) between the 1st semester of 2016 and the 1st semester of 2021, by region. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 01, 2026. /statistics/1116558/hiv-aids-prep-initiations-france-region/
ANSM. "Number of People Having Started Treatment with Truvada® or Generic for Pre-exposure Prophilaxis (Prep) between The 1st Semester of 2016 and The 1st Semester of 2021, by Region." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 30 Nov 2021, /statistics/1116558/hiv-aids-prep-initiations-france-region/
ANSM, Number of people having started treatment with Truvada® or generic for pre-exposure prophilaxis (PrEP) between the 1st semester of 2016 and the 1st semester of 2021, by region ÌÇÐÄÆƽâ°æ, /statistics/1116558/hiv-aids-prep-initiations-france-region/ (last visited August 01, 2026)
Number of people having started treatment with Truvada® or generic for pre-exposure prophilaxis (PrEP) between the 1st semester of 2016 and the 1st semester of 2021, by region [Graph], ANSM, November 30, 2021. [Online]. Available: /statistics/1116558/hiv-aids-prep-initiations-france-region/
